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Background and purpose   Hip resurfacing arthroplasty (RHA) is 
done in patients who often have a high preference for the method. 
This preference can influence the clinical outcome and satisfac-
tion. We evaluated the potential influence of this preference bias.
Patients and methods   From an ongoing randomized trial com-
paring RHA with total hip arthroplasty, 28 consecutive patients 
(28 hips) who had been allocated to an RHA were characterized 
as the “randomized” group. 22 other patients (24 hips) who had 
refused participation and had especially requested an RHA were 
characterized as the “preference” group. Harris hip score (HHS), 
Oxford hip score (OHS), University of California at Los Angeles 
activity scale (UCLA), Short Form 12 (SF-12), and visual analog 
scale satisfaction score (VAS) were assessed in both groups. 
Results   Both groups had a high implant satisfaction score 
(97/100 for the “preference” group and 93/100 for the “random-
ized” group) at 12 months. The HHS, OHS, and UCLA were simi-
lar at baseline and also revealed a similar improvement up to 12 
months (p < 0.001). Regarding the SF-12, the “preference” group 
scored lower on the mental subscale preoperatively (p = 0.03), and 
there was a greater increase after 12 months (p = 0.03).
Interpretation   We could not show that there was any influ-
ence of preference on satisfaction with the implant and early clini-
cal outcome in patients who underwent RHA. The difference in 
mental subscale scores between groups may still indicate a differ-
ence in psychological profile.
 
The outcome of any surgical treatment is influenced by several 
factors. Apart from the surgical intervention itself, co-morbid-
ities and postoperative rehabilitation—and also factors such 
as patients’ perception, confidence, and expectations—con-
tribute to the final result and patient satisfaction. Nowadays, 
most patients have access to the internet and other sources of 
information, and are well-informed. Their conceptions will 
lead beliefs and expectations, which will in turn lead to pref-
erences. Preference for a specific treatment can influence the 
outcome (Torgerson et al. 1996, McPherson et al. 1997, Van 
der Windt et al 2000, McPherson and Britton 2001, Thomas 
et al. 2004, Klaber Moffett et al. 2005) and can introduce bias 
into assessments of satisfaction and acceptability. This might 
be a confounding factor in a trial, and may affect the validity 
of the results. To obtain hard evidence of any possible prefer-
ence effects is problematic, as it is difficult to reliably dis-
tinguish between simple therapeutic effects and preference 
effects mediated through psychological pathways in experi-
ments (McPherson and Chalmers 1998). 
The dilemma of a possible influence of preference is fre-
quently encountered in studies in orthopedic surgery. For 
example, the interest in resurfacing hip arthroplasty (RHA) 
has grown in the past 15 years (National Joint Registry for 
England and Wales 2004, Chen et al. 2009, National Joint 
Registry for England and Wales 2009) and has received much 
international attention. The results reported regarding the 
short-term and long-term follow-up of RHA appear to cor-
respond with the results of conventional total hip arthroplasty 
(THA) (Pollard et al. 2006, Vail et al. 2006, Amstutz et al. 
2007, Khan et al. 2009, Mont et al. 2009, Lavigne et al. 2010) 
and the satisfaction rates reported have been 90–100% (Khan 
et al. 2009, Lingard et al. 2009, Mont et al. 2009). Hip resur-
facing surgeons generally deal with patients with a profound 
preference for this particular implant. We have not found any 
studies that have incorporated the possible influence of prefer-
ence of the patient for an RHA into their results, and it can be 
speculated whether these results are influenced by this prefer-
ence and perception on the part of the patients.
In an ongoing randomized trial comparing RHA with con-
ventional THA, we encountered—as expected—some diffi-
culty in recruiting patients for inclusion, since several patients 
had a specific demand for RHA. In this way, RHAs were per-
formed in 2 groups of patients: (1) an unbiased “randomized” 
group without any preferences, willing to participate in the 
ongoing trial, and simply allocated to RHA; and (2) a “prefer-
ence” group of “potentially biased” patients with a specific 
demand for RHA and who declined participation in the trial.
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bias on implant satisfaction and early clinical outcome. We 
hypothesized that patients in the “preference” group would be 
more satisfied than the patients in the “randomized” group. On 
the other hand, patients with a high degree of preference could 
have such high expectations of the treatment that they might 
be difficult to fulfill, which would lead to lower satisfaction 
compared to patients without any preference.
Patients and methods
From April 2007 through March 2010, patients under 65 years 
with primary arthritis of the hip were evaluated for eligibil-
ity to enter the randomized controlled trial (RCT) compar-
ing RHA with THA. After having given informed consent, 
patients with a strong preference for RHA (and who were 
therefore unwilling to be randomized) entered the prospective 
cohort study—the “preference” group. Patients with no pref-
erence were enrolled in the RCT to receive either an RHA or 
a THA. The current study included all patients in the “prefer-
ence” group and all patients in the RCT who were allocated to 
RHA, with a minimum follow-up of 6 months.
The criteria for inclusion in both the RCT and the cohort 
were identical: patients between 35 and 65 years old, eli-
gible for primary hip replacement because of osteoarthritis, 
congenital hip dysplasia, or posttraumatic arthritis. Patients 
were excluded in case of (previous) infection of the hip, hip 
fracture, avascular necrosis with collapse, osteoporotic bone 
mineral density index levels of the involved hip (t-score < 
2.5), renal failure, or hip revision of the primary index pro-
cedure. 
All patients received a Conserve Plus RHA (Wright Medi-
cal Technology, Arlington, TN). The operations were per-
formed through a standard posterolateral approach by a senior 
hip surgeon with considerable experience in RHA implants 
(Witjes et al. 2009). Both groups received identical antibiotic 
prophylaxis, periarticular ossification prophylaxis, and throm-
bosis prophylaxis during hospital admission, and 6 weeks 
afterwards. The patients had identical rehabilitation protocols 
with unrestricted weight bearing according to individual toler-
ance, starting on the first postoperative day.
50 patients were included in the study, with 28 implants 
(28 patients) in the “randomized” group and 24 implants (22 
patients) in the “preference” group (Figure 1 and Table). All 
patients in the “preference” group and 22 of the 28 patients in 
the “randomized” group completed the follow-up term of 12 
months. The remaining 6 patients had a follow-up of 6 months. 
All patients completed a questionnaire that included 
the Short Form 12 (SF-12) and Oxford hip score (OHS) 
preoperatively, at 6 months, and at 12 months. The Harris hip 
score (HHS) and the University of California at Los Ange-
les activity scale (UCLA) were assessed by an independent 
member of the research staff (AH) who collected and regis-
tered all the forms. Satisfaction with the implant was mea-
sured on a numeric scale (visual analog scale satisfaction 
score (VAS)) of 0–100 mm, where 100 mm corresponded to 
being completely satisfied. 
Approval for the randomized clinical trial and the cohort 
follow-up was obtained from the regional ethics committee of 
the Radboud University Nijmegen Medical Centre, with issue 
number LTC 419-071206 and date of approval 01/02/2007. 
All patients agreed to sign an informed consent document. 
The EudraCT number asigned to the randomized controlled 
trial was 2006-005610-12. 
 
Statistics
Variables were checked for normal distribution with the Shap-
iro-Wilk test. A value of < 0.05 was defined as the absence of 
a normal distribution. The mean and standard deviation (SD) 
were used for normally distributed variables and the median 
and interquartile range (IQR) for variables without normal 
distribution. Differences between the groups were determined 
by the Student’s t-test for variables with normal distribution, 
the Mann-Whitney test for variables without normal distribu-
tion, and the Pearson Chi-square test for categorical variables 
(sex and diagnosis). Variables that were not normally distrib-
uted were: age, blood loss, the preoperative OHS and UCLA 
scores, the VAS satisfaction score at 12 months, and the 
change in satisfaction score between 6 and 12 months. These 
p-values are marked with the superscript β. Significance was 
defined as p-values of < 0.05. SPSS software version 15.0 was 
used for statistical analysis.
Demographics of patients 
  “Preference”   “Randomized”  p-value
  group (n = 24)  group (n = 28)
Age
  median   52  58
  interquartile range  48–56  52–62  0.01
Sex: Male  15   13   0.2
Diagnosis     
  Osteoarthritis   24   26 
  Hip dysplasia   –   1  
  Avascular necrosis  –   1   0.5
82 hips 
24 denial RCT, 
preference cohort  
58 no preference 
RCT 
28 RHA  30 THA 
52 RHA included in 
this study 
Excluded 
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Results
The characteristics of the patients are given in Table 1. Both 
groups were similar regarding sex and diagnosis, but the 
patients in the “preference” group were younger than in the 
“randomized” group. Mean operation time (“preference” 
group: 81 min (SD 15); “randomized” group: 76 min (SD 
11); p = 0.2) and median blood loss (“preference” group: 300 
(288–313) mL; “randomized” group: 300 (200–300) mL; p = 
0.4β) were similar in both groups. Similar implants sizes were 
used in both groups (p = 0.7). 
The preoperative HHS, OHS, and UCLA scores were simi-
lar in both groups (Figure 2). The SF-12 score, however, was 
higher (88 (SD 14)), in the “randomized” group than in the 
“preference” group (80 (SD 12)) (p = 0.03). This difference 
mainly originated from intergroup differences in the mental 
subscale. A mean score of 47 (SD 13) on the mental subscale 
was found in the “preference” group, as opposed to 53 (SD 10) 
in the “randomized” group (p = 0.05).
The HHS, OHS, and UCLA scores all showed a postopera-
tive improvement at 12 months compared to the preoperative 
baseline scores for both groups (p < 0.001) (Figure 2). These 
improvements were similar between the groups (p = 0.8, 
p = 0.7, and p = 0.4, respectively). For the SF-12, however, 
at 12 months a better recovery was achieved from preopera-
tive levels in the “preference” group than in the “randomized” 
group (p = 0.03). 
Patient satisfaction (VAS) was assessed at 6 and 12 months 
for both groups. Both groups had a high satisfaction score, 
with a median of 97 for the “preference” group and 93 for 
the “randomized” group at the 12-month follow-up (p = 0.7β). 
Similar scores were obtained at the 6-month follow-up. 
2 complications occurred in the “preference” group. 1 
patient had a perioperative collum fissure with a delayed, but 
uneventful, recovery—and with clinical and satisfaction scores 
that matched within the interquartile range. Another patient 
had complaints of possible anterior impingement of the RHA. 
This patient had clinical and satisfaction scores that dropped 
Figure 2. Clinical scores (HHS, Oxford, SF-12 and UCLA) with 95%-confidence interval preoperatively, at 6 and 12 months. 
* In the horizontal axis of the SF-12 score represents a significant difference at baseline preoperative scores (p<0.05).164  Acta Orthopaedica 2011; 82 (2): 161–165
below the interquartile range. With exclusion of both patients, 
the median satisfaction score remained at 97 for the “prefer-
ence” group and 93 for the “randomized” group (p = 0.6β). 
With this exclusion, there were minimal changes in clinical 
scores, but with no consequences for the differences between 
the “preference” group and the “randomized” group (p = 1.0, 
p = 0.9, p = 0.3, and p = 0.01 for HHS, OHS, UCLA, and 
SF-12, respectively). The other 50 RHAs all had an uneventful 
clinical course.
Discussion
In this prospective comparative study, patient satisfaction 
and early clinical outcome in “biased” patients with a high 
preference for resurfacing hip arthroplasty (the “preference” 
group) did not differ statistically significantly from the results 
in unbiased patients who were simply allocated to an RHA 
after randomization in a separate randomized controlled trial 
(the “randomized” group). There was, however, a trend toward 
better satisfaction in the “preference” group. Only for the pre-
operative SF-12 values, and for the mental subscale in particu-
lar, was any statistically significant difference between groups 
encountered, in favor of the “randomized” group. 
In spite of the fact that the potential bias from treatment 
preferences is a well-recognized phenomenon in orthopedic 
practice, there have only been a few studies dealing with this 
clinical dilemma. Van der Windt et al. (2000), for example, 
demonstrated a success rate of 85% in patients with shoulder 
pain who received their preferred therapy compared to a 64% 
success for those who underwent the same treatment against 
their preference. In another study (Thomas et al. 2004), any 
direct influence of preference for a certain therapy on shoulder 
pain could not be confirmed; however, the authors revealed 
that in general patients with a preference before randomiza-
tion tended to have a better overall outcome than those with 
no preference.
 Randomized controlled trials are usually regarded as the 
gold standard in comparing 2 therapeutic treatments, as they 
diminish possible confounding factors. To study the potential 
influence of preference bias on the outcome of one and the 
same surgical procedure, randomization is, however, not a fea-
sible tool for obvious reasons. Our randomized controlled trial 
on THA and RHA confirmed for us the existence of patient 
preference for RHA; it was difficult to recruit patients for the 
trial. Many patients had a preference for RHA even after being 
informed about the absence of any evidence in the literature of 
a benefit of RHA over a conventional THA (Mont et al. 2009, 
Lavigne et al. 2010). The presence of a cohort of patients with 
a clear preference for RHA and a group of patients allocated 
to RHA after randomization enabled us to gain some insight 
into the possible role of preference bias.
Our study had some limitations, however. The number of 
patients in both groups was small, eventually resulting in a 
power of 59% to detect a clinical significant difference of 10 
on the VAS for patient satisfaction in a post hoc power analy-
sis. A power of 80% was calculated to detect a difference of 13 
on the VAS for patient satisfaction. Clearly, there was a small 
difference in outcome between the groups and a larger number 
of patients may eventually have revealed a statistically signifi-
cant difference in patient satisfaction between the groups. On 
the other hand, the power in our study was substantial enough 
for us to question whether such a difference would have been 
of clinical importance. 
Another limitation of our study may have been the short 
follow-up. However, Khan et al. (2009) evaluated the Bir-
mingham hip arthroplasty in a 5–8-year follow-up and dem-
onstrated that the satisfaction rate did not change substantially 
after the first postoperative year. Lingard et al. (2009) also 
showed a ceiling effect after 1 year. In addition, it is debat-
able whether a potential difference in satisfaction after 1 year 
would be influenced by preference, because expectations 
would be most manifest in the short period after the operation. 
2 patients with a bilateral prosthesis were included. One 
must assume that the outcome of 2 prostheses in the one 
patient cannot be interpreted independently. The result of the 
first prosthesis can either positively or negatively influence the 
outcome of the second, and vice versa (Bryant et al. 2006). 
Study outcome in general may be biased by this phenomenon; 
however, the number of bilateral prostheses in our study was 
low and exclusion of the 2 patients with bilateral prostheses did 
not have any consequences for our findings (data not shown).
Apart from the presence or absence of a profound prefer-
ence for an RHA, both groups matched regarding most demo-
graphic features and preoperative functional scores. The size 
of the femoral component of the implant was similar in both 
groups. This is important, as component size is known to 
influence the outcome of RHA (Crowninshield et al. 2004, 
Prosser et al. 2010). 
The only differences between the groups were age and 
preoperative SF-12 score. The difference in age between the 
groups suggests that younger patients are less willing to par-
ticipate in a randomized clinical trial. As for the SF-12, and for 
the mental subscale in particular, patients in the “preference” 
group had a lower preoperative score. There were no outli-
ers that could explain this difference between the groups. One 
could argue whether there is reason to believe that patients 
with a high preference for a certain treatment generally have 
a different psychological profile than patients who are willing 
to participate in a randomized trial. This finding has been rec-
ognized before (McPherson et al. 1997). 
In conclusion, we could not demonstrate any influence of 
preference on implant satisfaction and early clinical outcome 
in patients with an RHA. A trend towards a relatively higher 
degree of satisfaction was nevertheless established for patients 
with a specific request for RHA. The significant difference in 
mental subscale scores encountered between groups may indi-
cate a difference in psychological profile.Acta Orthopaedica 2011; 82 (2): 161–165  165
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